Phagos
PrivateLast Round
Series A
Oct 8, 2025
Total Funding Raised
$32.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Phagos is a biotechnology company that develops AI-driven bacteriophage therapies to combat bacterial diseases, initially focusing on animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phagos Comparables
Compare Phagos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proteon Pharmaceuticals | 82% | |
| Cytophage Technologies | 77% | |
| Vetophage | 74% | |
Phagos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 8, 2025 | ||||
| Seed | Sep 27, 2022 |
Key People
Founding team and executive leadership
Phagos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CapHorn Invest | Series A |
| Hoxton Ventures | Series A, Seed |
| Founders Capital | Series A |
| Acurio Ventures | Series A |
| AgFunder | Series A, Seed |
| Entrepreneurs First | Series A, Seed |
| Citizen Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Open roles increased to 61, 81% of headcount.
- Jul 20, 2026
Open roles increased to 30, 41% of headcount.
Phagos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phagos's valuation, stock price, and market status.